Table: Kringle Pharma -2023/24 parent results

Kringle Pharma

13/11/2024 06:40

Nov 13 (Reuters)- 
          Kringle Pharma, Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended       Year ended        Year to         NEXT   
               Sep 30, 2024     Sep 30, 2023     Sep 30, 2025      YEAR     
                  LATEST          YEAR-AGO         COMPANY        COMPANY   
                 RESULTS          RESULTS          FORECAST     H1 FORECAST 
  Sales           80 mln           69 mln          272 mln                  
               (+15.6 pct)      (-82.3 pct)      (+239.8 pct)               
  Operating    loss 817 mln     loss 888 mln      loss 1.38                 
  Recurring    loss 754 mln     loss 852 mln      loss 1.38                 
  Net          loss 756 mln     loss 854 mln      loss 1.38                 
  EPS        loss 118.21 yen  loss 158.46 yen  loss 202.70 yen              
  Ann Div          NIL              NIL              NIL                    
  -Q2 Div          NIL              NIL              NIL                    
  -Q4 Div          NIL              NIL              NIL                    
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T